All SEC Filings :: Ligand Pharmaceuticals Incorporated (LGND)

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
03/06/19	8-K	Current report filing Related Documents EX-99.1			8
03/05/19	8-K	Current report filing Related Documents EX-2.1 EX-99.1			62
02/28/19	10-K	Annual report pursuant to Section 13 and 15(d) Related Documents EX-10.48 EX-21.1 EX-23.1 EX-31.1 EX-31.2 EX-32.1			144
02/13/19	4	Statement of changes in beneficial ownership of securities			1
02/13/19	4	Statement of changes in beneficial ownership of securities			1
02/13/19	4	Statement of changes in beneficial ownership of securities			1
02/13/19	4	Statement of changes in beneficial ownership of securities			1
02/13/19	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
02/12/19	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			6
02/12/19	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5